iRadimed Corporation $IRMD Shares Purchased by Uniplan Investment Counsel Inc.

Uniplan Investment Counsel Inc. boosted its stake in iRadimed Corporation (NASDAQ:IRMD) by 49.7% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 48,727 shares of the medical equipment provider’s stock after purchasing an additional 16,187 shares during the period. Uniplan Investment Counsel Inc. owned about 0.38% of iRadimed worth $2,557,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in IRMD. Roubaix Capital LLC acquired a new stake in iRadimed in the 1st quarter valued at approximately $2,526,000. Nuveen LLC acquired a new stake in iRadimed in the 1st quarter valued at approximately $1,418,000. Vanguard Group Inc. increased its holdings in iRadimed by 3.3% in the 1st quarter. Vanguard Group Inc. now owns 554,451 shares of the medical equipment provider’s stock valued at $29,098,000 after purchasing an additional 17,640 shares during the last quarter. Copeland Capital Management LLC increased its holdings in iRadimed by 3.2% in the 1st quarter. Copeland Capital Management LLC now owns 490,544 shares of the medical equipment provider’s stock valued at $25,744,000 after purchasing an additional 14,981 shares during the last quarter. Finally, Envestnet Asset Management Inc. increased its holdings in iRadimed by 20.3% in the 1st quarter. Envestnet Asset Management Inc. now owns 70,473 shares of the medical equipment provider’s stock valued at $3,698,000 after purchasing an additional 11,892 shares during the last quarter. Institutional investors and hedge funds own 92.34% of the company’s stock.

iRadimed Stock Performance

iRadimed stock opened at $71.99 on Friday. iRadimed Corporation has a fifty-two week low of $44.58 and a fifty-two week high of $74.00. The firm has a 50 day moving average price of $64.97 and a 200 day moving average price of $57.91. The company has a market capitalization of $915.71 million, a PE ratio of 44.44 and a beta of 1.02.

iRadimed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Monday, August 18th were paid a $0.17 dividend. The ex-dividend date was Monday, August 18th. This represents a $0.68 annualized dividend and a dividend yield of 0.9%. iRadimed’s payout ratio is 41.98%.

Insider Activity at iRadimed

In related news, Director Monty K. Allen sold 1,102 shares of the business’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $69.10, for a total transaction of $76,148.20. Following the completion of the transaction, the director owned 19,898 shares in the company, valued at approximately $1,374,951.80. The trade was a 5.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 36.80% of the stock is currently owned by company insiders.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.